Although [18F]GE-180 PET is widely been used in other disease entities such as neuroinflammatory diseases [37], so far, TSPO PET imaging is overall of limited value for extra-cerebral oncologic diseases and has only sporadically been evaluated in other cancer entities than GBM, such as malignant pancreatic lesions [38]. This evidence concerns the gene TSPO and cerebritis.